← Feed

Gilliam Joseph E

SEC Form 4 insider
PRESIDENT & COO · GLAUKOS Corp ($GKOS), Caris Life Sciences, Inc. ($CAI)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-2.6%-2.6%
3d111100%-2.6%-2.6%
1w111100%-2.4%-2.4%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$GKOSSEC Form 4bearish
Gilliam Joseph E · PRESIDENT & COO at GLAUKOS Corp · 48d agono track record yet
Sold 60,000 @ $179.74 avg · $10,784,659 · 2026-08-11

Form 4: Gilliam Joseph E sold GKOS

Gilliam Joseph E (PRESIDENT & COO at GLAUKOS Corp) reported an open-market sale of 60,000 shares of GKOS at an average $179.74, roughly $10,784,659, in a Form 4 filed 2026-08-13.

At post $189.45Now $163.81-13.5% since postedas of Sep 18, 4:30 PM ET
1d-2.6%
3d-2.6%
1w-2.4%
1m-11.7%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.